CRBX logo

Carbiotix AB (publ) Stock Price

NGM:CRBX Community·SEK 29.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

CRBX Share Price Performance

SEK 5.96
-2.46 (-29.22%)
SEK 5.96
-2.46 (-29.22%)
Price SEK 5.96

CRBX Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with adequate balance sheet.

6 Risks
0 Rewards

Carbiotix AB (publ) Key Details

SEK 2.3m

Revenue

SEK 114.0k

Cost of Revenue

SEK 2.2m

Gross Profit

SEK 16.7m

Other Expenses

-SEK 14.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-2.91
95.07%
-625.31%
0%
View Full Analysis

About CRBX

Founded
2014
Employees
9
CEO
Erik Deaner
WebsiteView website
carbiotix.com

Carbiotix AB (publ), a biotechnology company develops health testing and microbiome modulators to address a range of chronic and metabolic diseases. Its portfolio includes prebiotic ingredients and diagnostic testing services. The company develops CarbiAXOS, a second-generation prebiotic soluble fiber based on virgin and upcycled natural substrates containing arabinoxylo-oligosaccharides that is customized to meet customer needs to the production of short chain fatty acids or any other effect; and LinkGut, a health test. Carbiotix AB (publ) was incorporated in 2014 and is based in Lund, Sweden.

Recent CRBX News & Updates

Recent updates

No updates